New approaches to in vitro diagnosis of hepatitis C infection a reason for post transfusion hepatitis: Diagnostic value of determination of hepatitis C virus core antigen

Transfusion and Apheresis Science

Volumn 45, Issue 3, 2011, Pages 247-250

  Yuksel, Pelin ^a   Caliskan, Reyhan ^a   Ergin, Sevgi ^a   Aslan, Mustafa ^a   Celik, Deniz Gozde ^a   Saribas, Suat ^a   Ziver, Tevhide ^a   Yalciner, Altan ^b   Kocazeybek, Bekir ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Duzen Laboratories   (Turkey)

Author keywords

Antigen test; ELISA; HCV; Post transfusion hepatitis; Virus

Indexed keywords

HEPATITIS C ANTIGEN; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; POSTTRANSFUSION HEPATITIS; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

ALGORITHMS; BLOOD TRANSFUSION; CROSS-SECTIONAL STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIGENS; HUMANS; MALE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, VIRAL;

EID: 81955164147     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2011.10.002     Document Type: Article

References (22)

1. Huarte M.P., Casi M.A. Virology, diagnostic tests, epidemiology and transmission mechanisms of hepatitis C virus infection. An Sist Sanit Navar 2004, 27:41-49.
2. Davison S.M., Mieli-Vergani G., Sira J., Kelly D.A. Perinatal hepatitis C virus infection: diagnosis and management. Arch Dis Child 2006, 91:781-785.
3. Lima L.P., Pedro R.J., Rocha M.D. Mother-to-infant transmission of hepatitits C virus (HCV) in Brazil. J Trop Pediatr 2004, 50:236-238.
4. Schackman B.R., Oneda K., Goldie S.J. The cost effectiveness of elective cesarian delivery to prevent hepatitis C transmission in HIV-coinfected women. AIDS 2004, 18:1827-1834.
5. Laperche S., Le Marrec N., Girault A., Bouchardeau F., Servant-Delmas A., Maniez-Montreuil M. Simultaneous detection of hepatitis C virus (HCV) core antigen and anti-HCV antibodies improves the early detection of HCV infection. J Clin Microbiol 2005, 43:3877-3883.
6. Echevarría J., Avellón A., Jonas G., Hausmann M., Vockel A., Kapprell H.P. Sensitivity of a modified version of the ARCHITECT® Anti-HCV test in detecting samples with immunoblot-confirmed, low-level antibody to hepatitis C virus. J Clin Virol 2006, 35:368-372.
7. Kim S., Kim J.H., Yoon S., Park Y.H., Kim H.S. Clinical performance evaluation of four automated chemiluminescence immunoassays for hepatitis C virus antibody detection. J Clin Microbiol 2008, 46:3919-3923.
8. Krajden M., Shivji R., Gunadasa K., Mak A., McNabb G., Friesenhahn M. Et al Evaluation of the core antigen assay as a second line supplemental test for diagnosis of active hepatitis C virus infection. J Clin Microbiol 2004, 42:4054-4059.
9. Reddy A.K., Dakshinamurty K.V., Lakshmi V. Utility of HCV core antigen ELISA in the screening for hepatitis C virus infection in patients on hemodialysis. Indian J Med Microbiol 2006, 24(1):55-57.
10. Leary T.P., Gutierrez R.A., Muerhoff A.S., Birkenmeyer L.G., Desai S.M., Dawson G.J. A chemiluminescent, magnetic particle-based immunoassay for the detection of hepatitis C virus core antigen in human serum or plasma. J Med Virol 2006, 78:1436-1440.
11. Comanor L., Elkin C., Leung K., Krajden M., Kronquist K., Nicolas K. Successful genotyping of previously failed and low viral load specimens sung an HCV RNA qualitative assay based on transcription mediated amplification in conjunction with the line probe assay. J Clin Virol 2003, 28:14-26.
12. Barut H.S., Gunal O. Global and national epidemiology of hepatitis C. Klimik Derg 2009, 22:8-43. [in Turkish].
13. Lauer G.M., Walker B.D. Hepatitis C virüs infection. N Engl J Med 2001, 345:41-52.
14. Morota K., Fujinami R., Kinukawa H., Machida T., Ohno K., Saegusa H. A new sensitive and automated chemiluminescent microparticle immunoassay for quantitative determination of hepatitis C virus core antigen. J Virol Methods Apr 2009, 157:8-14.
15. Dawson G.J. HCV core antigen detection in seropositive samples. J Med Virol 2007, 79:52-53.
16. Ross R.S., Viazov S., Salloum S., Hilgard P., Gerken G., Roggendorf M. Analytical performance characteristics and clinical utility of a novel assay for quantification of total hepatitis C virus core antigen. J Clin Microbiol 2010, 48:1161-1168.
17. Park Y., Lee J.H., Kim B.S., Kim do Y., Han K.H., Kim H.S. New automated hepatitis C virus (HCV) core antigen assay as an alternative to real-time PCR for HCV RNA quantification. J Clin Microbiol 2010, 48:2253-2256.
18. Schnuriger A., Dominguez S., Valantin M.A., Tubiana R., Duvivier C., Ghosn J. Early detection of hepatitis C virus infection by use of a new combined antigen-antibody detection assay: potential use for high-risk individuals. J Clin Microbiol 2006, 44:1561-1563.
19. Fabrizi F., Lunghi G., Aucella F., Mangano S., Barbisoni F., Bisegna S. Novel assay using total hepatitis C virus (HCV) core antigen quantification for diagnosis of HCV infection in dialysis patients. J Clin Microbiol 2005, 43:414-420.
20. Bouzgarrou N., Fodha I., Othman S.B., Achour A., Grattard F., Trabelsi A. Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients. J Med Virol 2005, 77:502-508.
21. Medhi S., Potukuchi S.K., Polipalli S.K., Swargiary S.S., Deka P., Chaudhary A. Diagnostic utility of hepatitis C virus core antigen in hemodialysis patients. Clin Biochem 2008, 41:447-452.
22. Miedouge M., Saune K., Kamar N., Rieu M., Rostaing L., Izopet J. Analytical evaluation of HCV core antigen and interest for HCV screening in haemodialysis patients. J Clin Virol 2010, 48:18-21.